231
Views
19
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon & show all
Pages 2733-2744 | Published online: 02 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Peter MA Calverley, Alberto Papi, Clive Page, Paola Rogliani, Roberto W Dal Negro, Mario Cazzola, Arrigo F Cicero & Jadwiga A Wedzicha. (2022) The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1909-1920.
Read now

Articles from other publishers (18)

Elias Saad, Basheer Maamoun & Assy Nimer. (2023) Increased Red Blood Cell Distribution Predicts Severity of Chronic Obstructive Pulmonary Disease Exacerbation. Journal of Personalized Medicine 13:5, pages 843.
Crossref
Lauren H. Fairley, Shatarupa Das, Vivek Dharwal, Nadia Amorim, Karl J. Hegarty, Ridhima Wadhwa, Guntipally Mounika & Philip M. Hansbro. (2023) Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease. Antioxidants 12:4, pages 973.
Crossref
M. A. Karnaushkina. (2023) Clinical aspects of the use of erdosteine in respiratory diseases. Meditsinskiy sovet = Medical Council:4, pages 132-140.
Crossref
Ján Dindoš. (2023) Diagnosing and treating cough in the general practitioner's surgery. Medicína pro praxi 20:1, pages 25-33.
Crossref
V. V. Salukhov, A. V. Nikolaev, V. V. Ivanov, M. A. Zhurkin, A. A. Chugunov & D. A. Marchenko. (2022) Multifaceted properties of erdostein and its place in the treatment of respiratory tract diseases. Meditsinskiy sovet = Medical Council 16:18, pages 82-89.
Crossref
Isabel UWAGBOE, Ian M. ADCOCK, Federica LO BELLO, Gaetano CARAMORI & Sharon MUMBY. (2022) New drugs under development for COPD. Minerva Medica 113:3.
Crossref
Francesco NUCERA, Sharon MUMBY, Keshav R. PAUDEL, Vivek DHARWAL, Antonino DI STEFANO, Vincenzo CASOLARO, Philip M. HANSBRO, Ian M. ADCOCK & Gaetano CARAMORI. (2022) Role of oxidative stress in the pathogenesis of COPD. Minerva Medica 113:3.
Crossref
Peter J. Barnes. (2022) Oxidative Stress in Chronic Obstructive Pulmonary Disease. Antioxidants 11:5, pages 965.
Crossref
S. N. Avdeev, N. V. Trushenko, S. Yu. Chikina & O. A. Suvorova. (2022) The potential of erdosteine to reduce the rate of exacerbations of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:2, pages 253-259.
Crossref
Ruth M. Saunders, Michael Biddle, Yassine Amrani & Christopher E. Brightling. (2022) Stressed out - The role of oxidative stress in airway smooth muscle dysfunction in asthma and COPD. Free Radical Biology and Medicine 185, pages 97-119.
Crossref
Arianna Pani, Valeria Lucini, Silvana Dugnani & Francesco Scaglione. (2022) Erdosteine enhances antibiotic activity against bacteria within biofilm. International Journal of Antimicrobial Agents 59:3, pages 106529.
Crossref
Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart & Jianping Weng. (2021) Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological Reviews 73:3, pages 924-967.
Crossref
Elisabetta Zinellu, Angelo Zinellu, Alessandro G. Fois, Maria Carmina Pau, Valentina Scano, Barbara Piras, Ciriaco Carru & Pietro Pirina. (2021) Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review. Antioxidants 10:5, pages 710.
Crossref
Ankush Sharma, Devesh Tewari, Seyed Fazel Nabavi, Seyed Mohammad Nabavi & Solomon Habtemariam. (2021) Reactive oxygen species modulators in pulmonary medicine. Current Opinion in Pharmacology 57, pages 157-164.
Crossref
Jaromir Zatloukal, Kristian Brat, Katerina Neumannova, Eva Volakova, Karel Hejduk, Eva Kocova, Ondrej Kudela, Michal Kopecky, Marek Plutinsky & Vladimir Koblizek. (2020) Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Biomedical Papers 164:4, pages 325-356.
Crossref
Alberto Papi, Sergey Avdeev, Peter M.A. Calverley, Carlos R. Cordeiro, Milos Jesenak, Vladimir Koblížek, Diana Petkova, Paola Rogliani, Hesham Tarraf, Nikolaos Tzanakis, Ruxandra Ulmeanu, Esra Uzaslan & Yochai Adir. (2020) Use of mucolytics in COPD: A Delphi consensus study. Respiratory Medicine 175, pages 106190.
Crossref
Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2020) Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent. Drugs 80:17, pages 1799-1809.
Crossref
Peter J. Barnes. (2020) Oxidative stress-based therapeutics in COPD. Redox Biology 33, pages 101544.
Crossref